C4 Therapeutics Correlations

CCCC Stock

USD 4.05 0.10 2.41%

The current 90-days correlation between C4 Therapeutics and Eliem Therapeutics is 0.09 (i.e., Significant diversification). The correlation of C4 Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

C4 Therapeutics Correlation With Market

Significant diversification

The correlation between C4 Therapeutics and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in C4 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For information on how to trade CCCC Stock refer to our How to Trade CCCC Stock guide.

Moving together with CCCC Stock

0.63	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.64	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.66	IPSC	Century Therapeutics	Pair Corr
0.63	MDWD	Mediwound	Pair Corr
0.65	NKTX	Nkarta Inc	Pair Corr
0.61	AGL	agilon health	Pair Corr
0.61	CYRX	Cryoport	Pair Corr
0.62	KA	Kineta Inc	Pair Corr
0.62	TLK	Telkom Indonesia Tbk	Pair Corr

Moving against CCCC Stock

0.39	KZR	Kezar Life Sciences	Pair Corr
0.37	RNXT	RenovoRx	Pair Corr
0.6	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.52	T	ATT Inc Aggressive Push	Pair Corr
0.5	BAC	Bank of America Aggressive Push	Pair Corr
0.45	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.44	JPM	JPMorgan Chase Fiscal Year End 10th of January 2025	Pair Corr
0.42	INTC	Intel Fiscal Year End 23rd of January 2025	Pair Corr
0.41	HD	Home Depot	Pair Corr
0.34	HPQ	HP Inc	Pair Corr
0.31	CAT	Caterpillar Fiscal Year End 3rd of February 2025	Pair Corr

Related Correlations Analysis

	STTK	ELYM	PRLD	GLUE	FHTX	CYT	RZLT	IPSC	EWTX	MLYS
STTK		0.84	0.74	-0.38	0.49	-0.32	-0.48	0.69	-0.86	-0.77	STTK
ELYM	0.84		0.66	-0.54	0.39	-0.45	-0.44	0.62	-0.79	-0.58	ELYM
PRLD	0.74	0.66		-0.33	-0.01	-0.39	-0.55	0.7	-0.86	-0.56	PRLD
GLUE	-0.38	-0.54	-0.33		0.21	0.55	0.64	-0.5	0.39	0.25	GLUE
FHTX	0.49	0.39	-0.01	0.21		0.26	0.31	0.17	-0.21	-0.29	FHTX
CYT	-0.32	-0.45	-0.39	0.55	0.26		0.32	-0.42	0.28	0.03	CYT
RZLT	-0.48	-0.44	-0.55	0.64	0.31	0.32		-0.52	0.56	0.51	RZLT
IPSC	0.69	0.62	0.7	-0.5	0.17	-0.42	-0.52		-0.59	-0.34	IPSC
EWTX	-0.86	-0.79	-0.86	0.39	-0.21	0.28	0.56	-0.59		0.77	EWTX
MLYS	-0.77	-0.58	-0.56	0.25	-0.29	0.03	0.51	-0.34	0.77		MLYS
	STTK	ELYM	PRLD	GLUE	FHTX	CYT	RZLT	IPSC	EWTX	MLYS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ELYM	+ 0.84	STTK
MLYS	+ 0.77	EWTX
PRLD	+ 0.74	STTK
IPSC	+ 0.7	PRLD
IPSC	+ 0.69	STTK
PRLD	+ 0.66	ELYM

High negative correlations

EWTX	- 0.86	PRLD
EWTX	- 0.86	STTK
EWTX	- 0.79	ELYM
MLYS	- 0.77	STTK
EWTX	- 0.59	IPSC
MLYS	- 0.58	ELYM

Risk-Adjusted Indicators

There is a big difference between CCCC Stock performing well and C4 Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze C4 Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
STTK	4.97	(1.26)	0.00	(2.27)	0.00	0.00	7.03	(9.82)	52.02
ELYM	3.92	(0.89)	0.00	(4.85)	0.00	0.00	6.21	(9.35)	34.87
PRLD	4.00	(2.41)	0.00	(2.22)	0.00	0.00	5.82	(7.83)	51.12
GLUE	5.45	0.55	0.16	0.25	4.44	(7.51)	10.11	(8.29)	102.66
FHTX	4.06	(0.14)	0.02	0.06	4.43	(4.53)	8.50	(6.81)	34.64
CYT	2.76	0.52	0.13	1.20	2.57	(3.47)	10.00	(5.26)	36.14
RZLT	2.90	0.09	0.04	0.16	3.10	(3.34)	6.81	(5.54)	30.01
IPSC	3.83	(0.75)	0.00	(0.15)	0.00	0.00	6.21	(8.82)	23.66
EWTX	3.63	0.57	0.21	0.30	3.05	(4.27)	6.65	(5.51)	61.02
MLYS	2.62	(0.08)	0.02	0.07	3.43	(2.63)	6.27	(5.79)	20.98

C4 Therapeutics Corporate Management

Paige Mahaney	Chief Officer	Profile
Kelly Schick	Chief Officer	Profile
Isabel Chiu	Senior Development	Profile
Mr MBA	Chief Officer	Profile
Andrew Hirsch	Pres CEO	Profile
Leonard MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC